Subcutaneous Drug Delivery Market, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), b

Subcutaneous Drug Delivery Market, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), by Delivery Type (Prefilled Syringe, Autoinjector (Spring Type, Motorized Type, and Wearable Type), Prefilled Pen (Disposable and Reusable), Vial (Syringe), and Pump and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The market comprises products, which are available in reusable and disposable form. Disposable segment is expected to witness growth, owing to significant increase in self-administration of drugs to treat chronic diseases. Moreover, the shift from vial-and-syringe format, which is prone to dosing errors and low patient-compliance rates, to prefilled syringes that enable the use of disposable and single-use syringes already filled with a prescribed unit dose of medication, is expected to drive the market growth.
Market Dynamics
Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. Moreover, in 2021, YpsoMed developed YpsoMate SmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected with an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.
Key features of the study:
This report provides in-depth analysis of the global subcutaneous drug delivery market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global subcutaneous drug delivery market based on the following parameters – company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc., Novartis International AG, Insulet Corporation, West Pharmaceutical Services, Inc., and Gerresheimer AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market
Detailed Segmentation:
Global Subcutaneous Drug Delivery Market, By Usability:
Disposable
Reusable
Global Subcutaneous Drug Delivery Market, By Disease Indication:
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
Global Subcutaneous Drug Delivery Market, By Delivery Type:
Prefilled Syringe
Autoinjector
Spring Type
Motorized Type
Wearable Type
Prefilled Pen
Disposable
Reusable
Vial (Syringe)
Pump and Others
Global Subcutaneous Drug Delivery Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Subcutaneous Drug Delivery Market, By Region:
North America
By Usability:
Disposable
Reusable
By Disease Indication:
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
By Delivery Type:
Prefilled Syringe
Autoinjector
Spring Type
Motorized Type
Wearable Type
Prefilled Pen
Disposable
Reusable
Vial (Syringe)
Pump and Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Usability:
Disposable
Reusable
By Disease Indication:
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
By Delivery Type:
Prefilled Syringe
Autoinjector
Spring Type
Motorized Type
Wearable Type
Prefilled Pen
Disposable
Reusable
Vial (Syringe)
Pump and Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Usability:
Disposable
Reusable
By Disease Indication:
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
By Delivery Type:
Prefilled Syringe
Autoinjector
Spring Type
Motorized Type
Wearable Type
Prefilled Pen
Disposable
Reusable
Vial (Syringe)
Pump and Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Usability:
Disposable
Reusable
By Disease Indication:
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
By Delivery Type:
Prefilled Syringe
Autoinjector
Spring Type
Motorized Type
Wearable Type
Prefilled Pen
Disposable
Reusable
Vial (Syringe)
Pump and Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Usability:
Disposable
Reusable
By Disease Indication:
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
By Delivery Type:
Prefilled Syringe
Autoinjector
Spring Type
Motorized Type
Wearable Type
Prefilled Pen
Disposable
Reusable
Vial (Syringe)
Pump and Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
GCC
Israel
Rest of Middle East
Africa
By Usability:
Disposable
Reusable
By Disease Indication:
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
By Delivery Type:
Prefilled Syringe
Autoinjector
Spring Type
Motorized Type
Wearable Type
Prefilled Pen
Disposable
Reusable
Vial (Syringe)
Pump and Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Becton, Dickinson and Company*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Novo Nordisk A/S
Johnson & Johnson
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
Amgen, Inc.
F. Hoffmann-La Roche AG
Consort Medical plc
Eli Lilly and Company
Merck & Co., Inc.
Novartis International AG
Insulet Corporation
West Pharmaceutical Services, Inc.
Gerresheimer AG
“*” marked represents similar segmentation in other categories in the respective section.